Skip to content
Catalyst

PapersPMID:23343189

Meta-analysis of randomized controlled trials on magnesium in addition to beta-blocker for prevention of postoperative atrial arrhythmias after coronary artery bypass grafting.

BMC cardiovascular disorders2013The record ↗

  1. Finding, limited evidenceno difference foundAll-cause mortality

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “Overall mortality was not significantly affected by magnesium in addition to beta-blocker (OR 0.59, 95% CI 0.08-4.56, P = 0.62).”
    Study
    meta-analysis
    Effect
    0.59 odds ratio, 95% CI 0.08 to 4.56
    Dose studied
    IV bolus or continuous infusion, total dose beyond 35 mmol, given prophylactically before onset of arrhythmia; pooled across 5 trials with varying regimens
    Population
    Adults undergoing coronary artery bypass grafting in sinus rhythm preoperatively, given magnesium in addition to beta-blocker versus beta-blocker alone (beta-blocker constant background in both arms); postoperative mortality, 3 trials, 454 patients

Study record

Design
meta-analysis
Species
human
Population
Adults undergoing coronary artery bypass grafting (on-pump or off-pump), in sinus rhythm at the time of surgery; 5 RCTs, 1,251 patients, magnesium given in addition to beta-blocker versus the same type of beta-blocker alone
Participants
1,251
Comparator
an active treatment / placebo
Duration
not reported
Endpoints measured
4